Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme (Q45399278)
Jump to navigation
Jump to search
scientific article published on 5 November 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme |
scientific article published on 5 November 2008 |
Statements
1 reference
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme (English)
1 reference
Christopher B Granger
1 reference
Alain Cohen-Solal
1 reference
Karl Swedberg
1 reference
Salim Yusuf
1 reference
John J V McMurray
1 reference
Marc A Pfeffer
1 reference
Eric L Michelson
1 reference
CHARM Investigators
1 reference
Margareta Puu
1 reference
Scott D Solomon
1 reference
5 November 2008
1 reference
1 reference
29
1 reference
24
1 reference
3022-3028
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference